University of Nebraska
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Nebraska sits in the top decile of US sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count).
University of Nebraska: 407 sponsored US clinical trials, 51 recruiting.
University of Nebraska sponsors 407 registered US clinical trials on ClinicalTrials.gov, 51 of them currently recruiting, and 261 completed. 31 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Peripheral Arterial Disease, with 7 trials.
Top-decile sponsor footprint
University of Nebraska ranks in the top decile of sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
261 of 332 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
407 total, page 2 of 9
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502
Group Activities to Support Addiction Recovery
NCT07071883
Patient Utilization of Opioid Destruction Bags in the Post-op Period
NCT05875857
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
NCT05220046
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
NCT05621096
ADX-629 Therapy for Sjogren-Larsson Syndrome
NCT05443685
Hand-Arm Bimanual Intensive Therapy in Virtual Reality Versus Standard Hand-Arm Bimanual Intensive Therapy
NCT05867368
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
NCT05177536
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
NCT05069038
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
NCT04748419
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease
NCT04620551
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
NCT03386500
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer
NCT03073785
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer
NCT01750073
Whole Versus Partial Gland Boost During Prostate SBRT
NCT07574489
Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance
NCT07507006
COQ10 and Vitamin E for Off-Target Radiation Toxicity
NCT07668284
Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy
NCT06574048
Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood
NCT07493720
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
NCT07517705
Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton
NCT07393971
Post-operative Outcomes of Anterior Cervical Discectomy and Fusion Surgery With and Without Drain Placement
NCT06938607
Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy
NCT06811545
Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation
NCT07315165
Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids
NCT06882772
Impact of Holotropic Breathwork on Nursing Student Mental Health
NCT07106554
Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
NCT06747598
Hyaluronidase Via LADD Scleroderma-induced Microstomia
NCT05995626
Sensory Habituation in Autism Spectrum Disorders
NCT06247176
Incentive-based and Media Literacy Informed Approaches to Improve Vaping Cessation
NCT05586308
Enhancing Uptake of Preconception Care Services in Family Practice Clinics Using a Patient Centered Screening Tool
NCT06582160
Network Analysis of Bodywide Coordination Supporting Suprapostural Dexterity
NCT07060092
Porcine Membrane vs Bovine Wound Dressing in Human Tooth Extraction Sites
NCT05802602
Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial
NCT05802615
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
NCT05677633
Effects of Biofeedback on Walking Speed Post-stroke
NCT05420857
Hyperbaric Oxygen Therapy in Sickle Cell Pain
NCT03412045
Using Mobile Technology to Address the Trauma Mental Health Treatment Gap
NCT05374408
Effect of Computerized Cognitive Training in Persons With MS
NCT05345288
Rural HEART Camp Connect: A Feasibility Study
NCT05647759
The Influence of Capsaicin Gel During Exercise Within the Heat
NCT05298202
Efficiency And Quality In Post-Surgical Pain Therapy After Discharge
NCT05221866
The Influence of Menthol Gel During Exercise With Heat
NCT05302804
Impact of Muscle Temperature on Muscle Growth and Breakdown: Cooling During Resistance Training
NCT05302791
Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab
NCT05275543
High-intensity Exercise After Treatment
NCT04950010
HEART Camp Connect: A Feasibility Study
NCT05985395
The Loneliness Epidemic Tailoring Interventions to Reduce Loneliness and Pain
NCT05387447
Dose Response Relationship of Oxytocin on Irritability in Youths
NCT03863288
Exoskeleton Variability Optimization
NCT04338815
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 52 |
| Phase 3 | 10 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of Nebraska pipeline
51 recruiting of 407 indexed (13% open); 261 completed (64%).
Phase mix: 31 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Peripheral Arterial Disease (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Nebraska: open-pipeline peers nationwide
Peers matched on 407 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 407 trials (± recruiting share)
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Nebraska page
407 registered trials is a research-attention snapshot, not an endorsement of University of Nebraska or any single study.
- 51 of University of Nebraska's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Peripheral Arterial Disease is the condition University of Nebraska studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Nebraska pipeline card: 407 registered trials from official public datasets.Report a data error.